January 23, 2018 / 10:09 AM / a month ago

BRIEF-Shanghai Fudan-Zhangjiang Bio-Pharmaceutical ‍Expects To Record A Decrease In FY Net Profit

Jan 23 (Reuters) - Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd:

* ‍EXPECTS TO RECORD A DECREASE IN NET PROFIT OF GROUP BY APPROXIMATELY 50% FOR FY

* ‍EXPECTS DECREASE IN FY REVENUE OF GROUP BY APPROXIMATELY 20%

* EXPECTED DECREASE IN REVENUE DUE TO DECREASED REVENUE FROM LIBOD BY ABOUT 50% FOR FY ENDED 31 DEC 2017​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below